Temporin-1Tl

General Information


DRACP ID  DRACP00048

Peptide Name   Temporin-1Tl

Sequence  FVQWFSKFLGRIL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Rana temporaria

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Hut-78 Sezary syndrome  Lymphoma 100% Killing=10 µM Trypan blue assay Not available 1
K562 Blast phase chronic myelogenous leukemia, BCR-ABL9 positive; Chronic myeloid leukemia Leukemia 60% Killing=10 µM Trypan blue assay Not available 1
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia 20% Killing=10 µM Trypan blue assay Not available 1

Hemolytic Activity  Human erythrocytes: 94% Hemolysis=24 µM; 92% Hemolysis=12 µM; 48% Hemolysis=6 µM; 13% Hemolysis=3 µM; 3% Hemolysis=1.5 µM; 100% Hemolysis=40 µM

Normal (non-cancerous) Cytotoxicity  NIH 3T3: 100% Killing=40 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00048

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C83H121N19O16

Absent amino acids  ACDEHMNPTY

Common amino acids  F

Mass  185521

Pl  11.65

Basic residues  2

Acidic residues  0

Hydrophobic residues  8

Net charge  2

Boman Index  160

Hydrophobicity  82.31

Aliphatic Index  112.31

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  458.33

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 12133008

Title  Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles

Doi 10.1042/BJ20020806

Year  2002

Literature 2

Pubmed ID 21319749

Title  Structure-activity relationship, conformational and biological studies of temporin L analogues

Doi 10.1021/jm1012853

Year  2011

Literature 3

Pubmed ID 32786286

Title  A Noncytotoxic Temporin L Analogue with In Vivo Antibacterial and Antiendotoxin Activities and a Nonmembrane-Lytic Mode of Action

Doi 10.1021/acsinfecdis.0c00022

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.